Investor profile
XGEN Venture has backed 4 European tech companies across 4 funding rounds between 2024 and 2026, joining rounds totalling €273M. Most active in Healthtech. Data as of 21 Oct 2026.
Also recorded as: XGEN Ventures
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nouscom | Switzerland | 1 | €120M |
| NanoPhoria | Italy | 1 | €84M |
| Aptadir Therapeutics | Italy | 1 | €40M |
| Protembis | Germany | 1 | €30M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| NanoPhoria | Series A | €84M | 2025-10 |
| Protembis | Series B | €30M | 2024-03 |
